Technology | March 20, 2007

Cholesterol Testing Brought Directly to Consumers


Cholestech Corp., provider of point-of-care health management solutions for chronic disease, and Life Line Screening, provider of mobile preventive health screenings, have teamed up to bring cholesterol, glucose and c-reactive protein testing directly to consumers across the country. With 85 vans across the U.S. and 1.4 million participants per year, Life Line Screening, the leader in the emerging trend of consumer-accessible screenings for stroke, vascular disease and osteoporosis has selected the Cholestech point-of-care testing system to screen Americans for risk factors‚ LDX associated with stroke, heart disease, diabetes and inflammatory disorders.

The LDX testing system will become part of Life Line Screening’s current preventive health services, which include non-invasive ultrasound screenings for stroke, abdominal aortic aneurysm, peripheral arterial disease and osteoporosis.
In collaboration with Cholestech, Life Line Screening can provide its participants laboratory-accurate results of their complete lipid panel, including total cholesterol, LDL, HDL and triglycerides; blood glucose; and high sensitivity C-reactive protein.


Additional Content

News | Point of Care Testing

August 5, 2019 — A West Virginia-based rural medical outreach event showcased the use of point-of-care technology in an ...

Home August 05, 2019
Home
News | Point of Care Testing

July 26, 2017 — Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of ...

Home July 26, 2017
Home
News | Point of Care Testing | Dave Fornell

July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is once ...

Home July 17, 2017
Home
Feature | Point of Care Testing | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios

Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on ...

Home May 05, 2017
Home
Technology | Point of Care Testing

January 27, 2017 — HyperMed Imaging Inc. announced that it has received clearance from the U.S. Food and Drug ...

Home January 27, 2017
Home
Subscribe Now